These biomedical industries will usher in significant development opportunities

[pharmaceutical network market analysis] as an important part of national development of new economy, biomedicine is indispensable in the innovation and development strategy At present, with the progress of science and technology, the development of innovative pharmaceutical industry is speeding up, and China's biomedical industry is also growing Especially under the influence of the recent epidemic, some biomedical industries will usher in significant development opportunities The industrial Internet will enter the deep-water area under the epidemic situation We can clearly see the powerful power of Internet big data in industrial collaboration Through data, we can quickly realize the regional industry bottom finding, through data monitoring of regional enterprise capacity to achieve effective prevention and control of epidemic situation, and through data collaboration, we can realize cross regional transportation and handover of epidemic prevention materials In addition, the use of Internet big data can also make decision-making more accurate and effective, and can be widely used in all corners of the industry In the future, the integration development of big data and biomedicine is mainly reflected in three aspects: technology integration, factor integration and ecological integration, which respectively refers to the rise of digital medical products and services, which is the integration of biotechnology and big data technology; digitalization can further improve the industry productivity; and will gradually form the digital community of biomedical industry Innovative enterprises will usher in development opportunities Biotechnological drugs are the innovative drug categories vigorously developed by China's biomedical industry during the 13th Five Year Plan period According to the plan, by 2020, a large number of Biopharmaceutical Enterprises will be promoted to realize the integration of drug quality standards and systems with the world, among which at least 100 pharmaceutical preparation enterprises will obtain the certification of the United States, Europe, Japan and other developed countries and who, and realize the export of drugs; 10 to 20 chemical drugs and high-end preparations, 3 to 5 new Chinese medicines, 3 to 5 new biotechnology will be developed and promoted in accordance with the international pharmaceutical standards Technical drugs have been registered in developed countries in Europe and the United States, and their access to the international market has been accelerated Based on this, China's biomedical market will enter a stage of rapid development Among them, there will be more opportunities for powerful innovative pharmaceutical enterprises The rapid development of biological industry base in fact, due to the characteristics of high technology, high input, high added value and interdisciplinary, the biological medicine industry has the characteristics of clustering development Therefore, clustering in the form of parks can help biological medicine enterprises to quickly obtain technology, capital, talents and other resources, so as to promote their growth Since 2005, the national development and Reform Commission has identified 22 national biological industry bases At the same time, it is also vigorously supporting the construction of public service conditions of the base, enhancing the base's gathering capacity, and promoting the combination of industry and regional economic development Taking Shanghai as an example, a good atmosphere of innovation and entrepreneurship has been formed with Zhangjiang national base as the core, which consists of six modules: industrial group, incubation and innovation, education and training, research and development, professional services, and venture capital With the vigorous development of biomedical industry, the biological industry base will maintain rapid growth, or will present the trend of industrial agglomeration